It’s Biotech Stocks’ Time to Shine
Wall Street Journal
Bets on interest-rate cuts plus a surge in pharma deals mean the worst is likely over for the biotech sector.
https://www.wsj.com/articles/its-biotech-stocks-time-to-shine-7eb26f83
Understanding current events through the lenses of the past and future.
Wall Street Journal
Bets on interest-rate cuts plus a surge in pharma deals mean the worst is likely over for the biotech sector.
https://www.wsj.com/articles/its-biotech-stocks-time-to-shine-7eb26f83